Lifecore Biomedical Q1 Earnings Call Highlights
During its first-quarter earnings call, Lifecore Biomedical reported a revenue decline and net loss but highlighted new commercial site transfer programs expected to generate mid-seven-figure opportunities by 2028. The company reaffirmed full-year guidance for $120–$125 million in revenue and reiterated long-term growth targets.
Tickers: $LFCR
Topics: biotech cdmo financial_performance guidance